Last Price$64.9(1.2%)
Market Cap$82.3B
LTM Operating Cash Flow margin
2.4%
5Y avg
5.0%
Medical - Healthcare Plans industry
median
2.5%
Stock quality & Intrinsic value
5/10
2.2% undervalued
CVS Health Corporation Operating Cash Flow margin
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow margin | 4.4% | 4.0% | 4.2% | 4.5% | 4.1% | 5.0% | 5.5% | 5.4% | 4.6% | 5.8% | 5.6% | 5.7% | 4.3% | 4.6% | 5.0% | 5.9% | 6.3% | 5.0% | 3.8% | 2.4% |
Overvalued or undervalued?
Check the intrinsic value for CVS
and see if it's the right time to invest.
CVS Health Corporation (CVS) Operating Cash Flow margin comparison analysis
General
LTM Operating Cash Flow margin
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
CVS Health CorporationCVS
2.4%
4.2%
(43.6%)
1.2%
Median Peer Set
2.9%
8.7%
(2.4%)
1.5%
Oscar Health, Inc.OSCR
10.7%
56.5%
N/A
0.3%
Clover Health Investments, Corp.CLOV
9.5%
(41.5%)
(31.3%)
(10.5%)
UnitedHealth Group IncorporatedUNH
6.1%
8.9%
(35.7%)
3.6%
Cigna CorporationCI
4.2%
8.4%
(18.9%)
2.6%
Elevance Health Inc.ELV
3.3%
3.2%
(0.0%)
3.4%
Humana Inc.HUM
2.5%
10.7%
(50.1%)
1.0%
Molina Healthcare, Inc.MOH
1.6%
19.3%
9.2%
2.9%
Alignment Healthcare, Inc.ALHC
1.3%
27.2%
(4.8%)
(8.1%)
Centene CorporationCNC
0.1%
5.9%
27.4%
2.0%
Bright Health Group, Inc.BHG
(175.2%)
(51.9%)
86.2%
(103.4%)
CVS key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 37,006.7 21.0% | 43,821.4 18.4% | 76,329.5 74.2% | 87,472.0 14.6% | 98,215.0 12.3% | 95,778.0 (2.5%) | 107,080.0 11.8% | 123,120.0 15.0% | 126,761.0 3.0% | 139,367.0 9.9% | 153,290.0 10.0% | 177,546.0 15.8% | 184,786.0 4.1% | 194,579.0 5.3% | 256,776.0 32.0% | 268,706.0 4.6% | 292,111.0 8.7% | 322,467.0 10.4% | 357,776.0 10.9% | 372,809.0 4.2% |
| Cost of Goods Sold (COGS) | 27,312.1 | 32,079.2 | 60,221.8 | 69,182.0 | 77,857.0 | 75,559.0 | 86,518.0 | 100,632.0 | 102,978.0 | 114,000.0 | 126,762.0 | 148,712.0 | 156,258.0 | 163,041.0 | 211,248.0 | 219,660.0 | 239,991.0 | 267,965.0 | 303,345.0 | 321,408.0 |
% margin | 9,694.6 26.2% | 11,742.2 26.8% | 16,107.7 21.1% | 18,290.0 20.9% | 20,358.0 20.7% | 20,219.0 21.1% | 20,562.0 19.2% | 22,488.0 18.3% | 23,783.0 18.8% | 25,367.0 18.2% | 26,528.0 17.3% | 28,834.0 16.2% | 28,528.0 15.4% | 31,538.0 16.2% | 45,528.0 17.7% | 49,046.0 18.3% | 52,120.0 17.8% | 54,502.0 16.9% | 54,431.0 15.2% | 51,401.0 13.8% |
| Operating Expenses | 7,675.1 | 9,300.6 | 11,314.4 | 12,244.0 | 13,933.0 | 14,082.0 | 14,231.0 | 15,278.0 | 15,746.0 | 16,568.0 | 17,053.0 | 18,448.0 | 18,990.0 | 27,517.0 | 33,541.0 | 35,135.0 | 38,810.0 | 46,548.0 | 40,688.0 | 41,606.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 7,675.1 | 9,300.6 | 11,314.4 | 12,244.2 | 13,933.0 | 14,092.0 | 14,231.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (1,279.0) |
% margin | 2,019.5 5.5% | 2,441.6 5.6% | 4,793.3 6.3% | 6,046.0 6.9% | 6,425.0 6.5% | 6,137.0 6.4% | 6,331.0 5.9% | 7,210.0 5.9% | 8,037.0 6.3% | 8,799.0 6.3% | 9,475.0 6.2% | 10,386.0 5.8% | 9,538.0 5.2% | 4,021.0 2.1% | 11,987.0 4.7% | 13,911.0 5.2% | 13,310.0 4.6% | 7,954.0 2.5% | 13,743.0 3.8% | 8,516.0 2.3% |
| Interest Income | 0.0 | 0.0 | 0.0 | 21.0 | 5.0 | 3.0 | 4.0 | 4.0 | 8.0 | 15.0 | 21.0 | 20.0 | 21.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 530.0 | 530.0 | 539.0 | 588.0 | 561.0 | 517.0 | 615.0 | 859.0 | 1,078.0 | 1,062.0 | 2,619.0 | 3,035.0 | 2,907.0 | 2,503.0 | 2,287.0 | 2,658.0 | 2,958.0 |
| Pre-tax Income | 1,909.0 | 2,225.8 | 4,358.7 | 5,537.0 | 5,900.0 | 5,601.0 | 5,747.0 | 6,305.0 | 7,528.0 | 7,678.0 | 8,616.0 | 8,637.0 | 8,268.0 | 1,406.0 | 8,997.0 | 9,770.0 | 10,537.0 | 5,836.0 | 11,173.0 | 6,148.0 |
% effective tax rate | 684.3 35.8% | 856.9 38.5% | 1,721.7 39.5% | 2,193.0 39.6% | 2,200.0 37.3% | 2,179.0 38.9% | 2,258.0 39.3% | 2,436.0 38.6% | 2,928.0 38.9% | 3,033.0 39.5% | 3,386.0 39.3% | 3,317.0 38.4% | 1,637.0 19.8% | 2,002.0 142.4% | 2,366.0 26.3% | 2,569.0 26.3% | 2,548.0 24.2% | 1,509.0 25.9% | 2,805.0 25.1% | 1,562.0 25.4% |
% margin | 1,224.7 3.3% | 1,368.9 3.1% | 2,637.0 3.5% | 3,212.0 3.7% | 3,696.0 3.8% | 3,427.0 3.6% | 3,462.0 3.2% | 3,864.0 3.1% | 4,592.0 3.6% | 4,644.0 3.3% | 5,237.0 3.4% | 5,317.0 3.0% | 6,622.0 3.6% | (594.0) (0.3%) | 6,634.0 2.6% | 7,179.0 2.7% | 8,001.0 2.7% | 4,311.0 1.3% | 8,344.0 2.3% | 4,614.0 1.2% |
| EPS | 1.49 | 1.65 | 1.97 | 2.23 | 2.58 | 2.51 | 2.59 | 3.05 | 3.77 | 3.98 | 4.66 | 4.93 | 6.47 | (0.57) | 5.10 | 5.48 | 6.00 | 3.29 | 6.49 | 3.66 |
| Diluted EPS | 1.45 | 1.60 | 1.92 | 2.18 | 2.55 | 2.49 | 2.57 | 3.03 | 3.74 | 3.96 | 4.63 | 4.90 | 6.44 | (0.57) | 5.08 | 5.46 | 5.95 | 3.26 | 6.47 | 3.66 |
% margin | 2,608.6 7.0% | 3,174.9 7.2% | 5,887.9 7.7% | 7,341.0 8.4% | 7,819.0 8.0% | 7,609.0 7.9% | 7,903.0 7.4% | 8,619.0 7.0% | 9,915.0 7.8% | 10,224.0 7.3% | 11,567.0 7.5% | 12,190.0 6.9% | 11,809.0 6.4% | 6,743.0 3.5% | 16,403.0 6.4% | 17,118.0 6.4% | 17,526.0 6.0% | 12,347.0 3.8% | 18,197.0 5.1% | 13,703.0 3.7% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is CVS Health Corporation's Operating Cash Flow margin?
As of today, Microsoft Corp's last 12-month Operating Cash Flow margin is 2.4%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Operating Cash Flow margin for CVS Health Corporation have been 4.7% over the past three years, and 5.2% over the past five years.
2) Is CVS Health Corporation's Operating Cash Flow margin Good?
As of today, CVS Health Corporation's Operating Cash Flow margin is 2.4%, which is lower than industry median of 2.5%. It indicates that CVS Health Corporation's Operating Cash Flow margin is Bad.